Pulsed electric field (PEF) is a novel energy source by which high-voltage electric pulses are used to create irreversible electroporation. PEF is non-thermal and highly tissue-dependent in which specific targeting of the atrial myocardium is achieved and sparing of adjacent tissues is feasible, theoretically increasing the safety of the procedure, which could potentially break the trade-off between effective lesions and collateral damage and substantially improve risk-benefit ratios in atrial fibrillation (AF) ablation. Although recently published trials have shown a clear effect of AF ablation, large-scale clinical trials are lacking. Current clinical evidence has demonstrated significant efficacy in achieving durable pulmonary vein isolation without ablation-related adverse events. However, their putative benefits regarding efficacy, efficiency, and safety remain to be proven in randomized controlled trials.
N6‐methyladenosine (m 6 A) RNA methylation is correlated with carcinogenesis and dynamically possessed through the m 6 A RNA methylation regulators. This paper aimed to explore 13 m 6 A RNA methylation regulators' role in gastrointestinal cancer (GIC) and determine the risk model and prognosis value of m 6 A RNA methylation regulators in GIC. We used several bioinformatics methods to identify the differential expression of m 6 A RNA methylation regulators in GIC, constructed a prognostic model, and carried out functional enrichment analysis. Eleven of 13 m 6 A RNA methylation regulators were differentially expressed in different clinicopathological characteristics of GIC, and m 6 A RNA methylation regulators were nearly associated with GIC. We constructed a risk model based on five m 6 A RNA methylation regulators (METTL3, FTO, YTHDF1, ZC3H13, and WTAP); the risk score is an independent prognosis biomarker. Moreover, the five m 6 A RNA methylation regulators can also forecast the 1‐, 3‐ and 5‐year overall survival through a nomogram. Furthermore, four hallmarks of oxidative phosphorylation, glycolysis, fatty acid metabolism, and cholesterol homoeostasis gene sets were significantly enriched in GIC. m 6 A RNA methylation regulators were related to the malignant clinicopathological characteristics of GIC and may be used for prognostic stratification and development of therapeutic strategies.
1 January 1997 in Collection of Czechoslovak Chemical Communications
The first stereoselective synthesis of 2α,3α-epoxy-9β-benzoyloxy-β-agarofuran (3) and 2,3-dehydro-4β,12-epoxy-9β-benzoyloxy-β-dihydroagarofuran (4) from (-)-carvone in 13 steps, respectively, has been described. In addition, the synthesis of 2,3-dehydro-4β,9β-dihydroxy-β-dihydroagarofuran (13) has also been reported. By the reduction of 4 to give 13, the 4β,12-epoxy configuration of 4 was established.
1 January 2023 in Combinatorial Chemistry & High Throughput Screening
Background Gastrointestinal cancer (GIC) is a prevalent and lethal malignant tumor. It is obligatory to investigate innovative biomarkers for the diagnosis and prognosis. Proteins play a crucial role in regulating the occurrence and progression of GIC. However, the prognostic value of proteins is unclear in GIC. Objective: This paper aims to identify the hub prognosis-related proteins (PAPs) and construct a prognosis model to GIC patients for clinical application. Methods: Protein expression data of GIC were obtained from The Cancer Proteome Atlas (TCPA) and downloaded the clinicopathological data from The Cancer Genome Atlas database (TCGA). Besides, hub proteins were filtrated out via univariate and multivariate Cox regression analysis. Moreover, survival analysis and nomogram were used to predict overall survival (OS). We used the calibration curves to assess the predictive and actual survival rate consistency. The consistency index (C-index) was used to evaluate the prognostic ability of the predictive model. Furthermore, functional enrichment analysis and protein co-expression of PAPs were used to explore their roles in GIC. Results: Finally, a prognosis model was conducted based on ten PAPs (CYCLIND1, DVL3, NCADHERIN, SYK, ANNEXIN VII, CD20, CMET, RB, TFRC, and PREX1). The risk score calculated by the model was an independent prognostic predictor. Compared with the high-risk subgroup, the low-risk subgroup had better OS. In the TCGA cohort, the area under the curve value of the receiver operating characteristic curve of the prognostic model was 0.692. The expression of proteins and risk score had a significant association with the clinicopathological characteristics of GIC. Besides, nomogram based on GIC clinicopathological feature and risk score could properly predict the OS of individual GIC patients. The C-index is 0.71 in the TCGA cohort and 0.73 in the GEO cohort, respectively. Conclusion: The results indicate that the risk score is an independent prognostic biomarker and is related to the malignant clinical features of GIC patients. Besides, several PAPs, associated with the survival and clinicopathological characteristics of GIC might be potential biomarkers for GIC diagnosis and treatment.